Latest news
MoonLake announces positive Phase 3 psoriatic arthritis results - TipRanksTipRanks · Mon, 10 Aug 2026 11:59:38 GMTMoonLake says Phase 3 IZAR-1 trial met all clinical endpoints at Week 16 - TipRanksTipRanks · Mon, 10 Aug 2026 11:41:30 GMTMoonLake reports positive Phase 3 PsA data and $537 million cash - Quiver QuantitativeQuiver Quantitative · Mon, 10 Aug 2026 11:20:00 GMTMoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:23 GMTOrion Oyj - via.ritzau.dkvia.ritzau.dk · Mon, 10 Aug 2026 11:05:00 GMTTilray Brands, Inc. - via.ritzau.dkvia.ritzau.dk · Mon, 10 Aug 2026 11:00:00 GMT